Redmile Group as of June 30, 2015
Portfolio Holdings for Redmile Group
Redmile Group holds 55 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Array BioPharma | 8.1 | $98M | 14M | 7.21 | |
Amicus Therapeutics (FOLD) | 7.3 | $89M | 6.3M | 14.15 | |
Valeant Pharmaceuticals Int | 7.0 | $85M | 385k | 222.15 | |
Clovis Oncology | 5.5 | $67M | 760k | 87.88 | |
Teva Pharmaceutical Inds Adr (TEVA) | 4.7 | $57M | 967k | 59.10 | |
Allergan SHS | 3.4 | $42M | 137k | 303.46 | |
Kythera Biopharmaceuticals I | 3.0 | $36M | 483k | 75.31 | |
Hca Holdings (HCA) | 2.9 | $35M | 390k | 90.72 | |
Abbvie (ABBV) | 2.8 | $34M | 510k | 67.19 | |
Aetna | 2.8 | $34M | 264k | 127.46 | |
Chimerix (CMRX) | 2.6 | $32M | 699k | 46.20 | |
CIGNA Corporation | 2.6 | $32M | 199k | 162.00 | |
Biogen Idec (BIIB) | 2.6 | $32M | 79k | 403.94 | |
BioMarin Pharmaceutical (BMRN) | 2.3 | $28M | 208k | 136.78 | |
Receptos | 2.2 | $27M | 144k | 190.05 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.2 | $27M | 151k | 176.07 | |
Seattle Genetics | 2.1 | $26M | 529k | 48.40 | |
Universal Hlth Svcs CL B (UHS) | 2.0 | $25M | 176k | 142.10 | |
Health Net | 2.0 | $25M | 388k | 64.12 | |
Alere | 2.0 | $24M | 461k | 52.75 | |
Nanostring Technologies (NSTGQ) | 1.8 | $23M | 1.5M | 15.42 | |
Sage Therapeutics (SAGE) | 1.7 | $21M | 290k | 73.00 | |
Insmed Com Par $.01 (INSM) | 1.7 | $21M | 867k | 24.42 | |
Atara Biotherapeutics (ATRA) | 1.6 | $20M | 373k | 52.76 | |
Intra Cellular Therapies (ITCI) | 1.6 | $20M | 610k | 31.95 | |
Gw Pharmaceuticals Ads | 1.5 | $18M | 146k | 122.84 | |
Incyte Corporation (INCY) | 1.4 | $17M | 165k | 104.21 | |
Model N (MODN) | 1.4 | $17M | 1.4M | 11.91 | |
Oxford Immunotec Global Ord Shs | 1.4 | $17M | 1.2M | 13.85 | |
Castlight Health CL B | 1.3 | $16M | 2.0M | 8.14 | |
Zs Pharma | 1.3 | $16M | 303k | 52.39 | |
Oncothyreon | 1.3 | $16M | 4.2M | 3.74 | |
Civitas Solutions | 1.1 | $14M | 658k | 21.33 | |
Fate Therapeutics (FATE) | 1.1 | $13M | 2.0M | 6.47 | |
DaVita (DVA) | 0.9 | $11M | 140k | 79.47 | |
Blueprint Medicines (BPMC) | 0.8 | $9.7M | 378k | 25.57 | |
Avalanche Biotechnologies In | 0.7 | $8.7M | 537k | 16.24 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.7 | $8.6M | 517k | 16.67 | |
Genocea Biosciences | 0.7 | $8.6M | 624k | 13.73 | |
D Fluidigm Corp Del (LAB) | 0.7 | $8.4M | 348k | 24.20 | |
Cerus Corporation (CERS) | 0.7 | $8.3M | 1.6M | 5.19 | |
Trivascular Technologies | 0.6 | $7.8M | 1.5M | 5.35 | |
Portola Pharmaceuticals | 0.6 | $7.0M | 153k | 45.55 | |
Ultragenyx Pharmaceutical (RARE) | 0.6 | $6.9M | 67k | 102.40 | |
Bellicum Pharma | 0.4 | $5.1M | 238k | 21.27 | |
Array Biopharma Note 3.000% 6/0 (Principal) | 0.4 | $5.1M | 4.0M | 1.26 | |
Chemocentryx | 0.3 | $3.9M | 476k | 8.23 | |
Eleven Biotherapeutics | 0.3 | $3.6M | 1.3M | 2.82 | |
Flexion Therapeutics | 0.3 | $3.1M | 143k | 21.89 | |
Axovant Sciences | 0.3 | $3.1M | 150k | 20.38 | |
Invitae (NVTAQ) | 0.2 | $2.6M | 181k | 14.14 | |
Aduro Biotech | 0.2 | $1.9M | 62k | 30.34 | |
Ishares Us Hlthcr Pr Etf (IHF) | 0.1 | $1.2M | 8.6k | 142.92 | |
Celldex Therapeutics | 0.1 | $826k | 33k | 25.21 | |
Market Vectors Etf Tr Pharmaceutical | 0.0 | $460k | 6.5k | 70.77 |